Skip to content

Health Effect of Canola Oil Consumption in Shift Workers

The Effect of Canola Oil Consumption on the Selected Cardiometabolic Parameters in a Group of Shift Workers

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03977558
Enrollment
40
Registered
2019-06-06
Start date
2018-10-30
Completion date
2019-12-31
Last updated
2019-06-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diet Modification, Metabolic Syndrome, Shift-Work Related Sleep Disturbance, Work-Related Condition

Keywords

Shift Work, Night Work, Rotating Shift Work, Metabolic Syndrome, Diet Therapy, Canola oil, Fatty Acids, Cardiometabolic parameters

Brief summary

Shift work is associated with a higher risk of the development of cardiometabolic syndrome (CMtS) than in people working only during the day. One of the factors predisposing to the development of the CMtS in shift workers is an inappropriate composition of their diet. It was observed that the shift workers diet is characterized by a higher intake of saturated fatty acids (SFA) and a lower consumption of unsaturated fatty acids. One potential way to reduce the risk of CMtS in this study group seems to be a modification of their everyday diet by excluding the products of animal origin (e.g. butter) with simultaneously including vegetable oils (i.e. canola oil). The aim of the study is to evaluate the effect of replacement in the everyday diet of saturated fats (butter) with unsaturated fats (canola oil-based spread and canola oil added to main meals) in centrally obese shift workers on changes in body weight and body composition parameters as well as on changes in CMtS markers.

Detailed description

The study was designed as a randomized clinical trial to investigate the effects of the dietary intervention with moderate in fat content (\ 35% energy as fat) for 12 weeks on the improvement of cardiometabolic risk factors in centrally obese shift workers. Forty centrally obese shift workers (waist circumference ≥94 cm) were randomized (1:1) to the experimental group (n = 20) or the control group (n = 20). Eligibility criteria included: aged between 30-60 years, working rotating shifts for at least 5 years and working night shifts minimum five times a month. Excluded criteria was described in the point Eligibility. Written informed consent was obtained from all of the participants, and the local ethic committee approved the study. The dietary intervention was mainly based on the simple rearrangement of shift workers' diets by replacing food items including SFA (e.g. butter) with those being sources of unsaturated fatty acids (UFA), mainly canola oil (given to the diet as spread or this oil was added separately to main meals)

Interventions

BEHAVIORALIntervention group

Isocaloric diet including \ 50g canola oil

BEHAVIORALControl group

ESC/EAS Guidelines for the management of dyslipidemias

Sponsors

Poznan University of Life Sciences
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
MALE
Age
30 Years to 60 Years
Healthy volunteers
Yes

Inclusion criteria

* centrally obese (≥ 94cm) male * aged between 30-60 years, * working rotating shifts for at least 5 years and working night shifts minimum five times a month,

Exclusion criteria

* diabetes, familial hypercholesterolemia, thyroid and parathyroid diseases, non-specific intestinal diseases, celiac disease, phenylketonuria, * taking medication for lowering blood lipids such as statins, * weight loss therapy for 3 months before the intervention, * allergies and intolerances * consuming high-proof alcoholic beverages (\>2 portions/week)

Design outcomes

Primary

MeasureTime frameDescription
Waist circumference (WC)Baseline, 4, 8 and 12 weekChanges in WC within groups and between groups
HDL-cholesterol (HDL-C)Baseline, 12 weekChanges in HDL-C within groups and between groups
LDL-cholesterol (LDL-C)Baseline, 12 weekChanges in LDL-C within groups and between groups
Triglycerides (TG)Baseline, 12 weekChanges in TG within groups and between groups
Glucose (GLU)Baseline, 12 weekChanges in GLU within groups and between groups
Blood pressure (BP)Baseline, 12 weekChanges in BP within groups and between groups
Body weight (BW)Baseline, 4, 8 and 12 weekChanges in BW within groups and between groups
Fat mass (FM)Baseline, 4, 8 and 12 weekChanges in FM within groups and between groups

Secondary

MeasureTime frameDescription
Melatonin (MEL)Baseline, 12 weekChanges in MEL within groups and between groups
High-sensitivity C-reactive Protein (hs-CRP)Baseline, 12 weekChanges in hs-CRP within groups and between groups
Dietary intakeBaseline, 4, 8, 12 weekChanges in dietary intake within groups and between groups
Fatty acids (FA) erythrocyte membranes concentrationBaseline, 12 weekChanges in FA within groups and between groups
Cardiotrophin-1 (CT-1)Baseline, 12 weekChanges in CT-1 within groups and between groups
Lipase (LPS)Baseline, 12 weekChanges in LPS within groups and between groups
Cholinesterase (CHE)Baseline, 12 weekChanges in CHE within groups and between groups respectively
Alanine transaminase (ALT)Baseline, 12 weekChanges in ALT within groups and between groups
Aspartate transaminase (AST)Baseline, 12 weekChanges in AST within groups and between groups
Insulin (INS)Baseline, 12 weekChanges in INS within groups and between groups
Gamma-glutamyltransferase (GGTP)Baseline, 12 weekChanges in GGTP within groups and between groups

Countries

Poland

Contacts

Primary ContactAgnieszka Kuleta-Koberska, MSc
agnieszka.kuleta@up.poznan.pl+48618467594
Backup ContactJoanna Bajerska, Prof.
joanna.bajerska@up.poznan.pl+48618466056

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026